Evidence map›Paper›PMID 38396202›Full record

ArticleCommunications biology2024

In-silico testing of new pharmacology for restoring inhibition and human cortical function in depression.

Alexandre Guet-McCreight, Homeira Moradi Chameh, Frank Mazza, Thomas D Prevot, Taufik A Valiante, Etienne Sibille, Etay Hay

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Large-Scale Mechanistic Models of Brain Circuits with Biophysically and Morphologically Detailed Neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Alexandre Guet-McCreightKrembil Centre for Neuroinformatics, Centre for Addiction and Mental Health, Toronto, ON, Canada. alexandre.guet-mccreight@camh.ca.ORCID 0000-0002-2377-0337
Homeira Moradi ChamehKrembil Brain Institute, University Health Network, Toronto, ON, Canada.
Frank MazzaKrembil Centre for Neuroinformatics, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Thomas D PrevotDepartment of Psychiatry, University of Toronto, Toronto, ON, Canada.
Taufik A ValianteKrembil Brain Institute, University Health Network, Toronto, ON, Canada.ORCID 0000-0002-3443-3790
Etienne SibilleDepartment of Psychiatry, University of Toronto, Toronto, ON, Canada.ORCID 0000-0001-5832-6570
Etay HayKrembil Centre for Neuroinformatics, Centre for Addiction and Mental Health, Toronto, ON, Canada. etay.hay@camh.ca.ORCID 0000-0001-8136-6124
Centre for Addiction and Mental Health · CAUniversity Health Network · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reduced inhibition by somatostatin-expressing interneurons is associated with depression. Administration of positive allosteric modulators of α5 subunit-containing GABA

Indexed as

DepressionReceptors, GABA-ABrainHumansInterneuronsNeuronsReceptors, GABA-A

Identifiers

PMID38396202
PMCPMC10891083
OpenAlexW4392111352

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.